Lord, Abbett & Co
MJN

Lord, Abbett & Co’s Mead Johnson Nutrition Company MJN Stock Holding History

Lord, Abbett & Co’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-140,650
Closed -$9.95M – 970
2016
Q4 		$9.95M Buy
140,650
+79,006
+128% +$5.89M 0.03% 585
2016
Q3 		$4.87M Sell
61,644
-912
-1% -$77.8K 0.01% 742
2016
Q2 		$5.68M Sell
62,556
-2,514
-4% -$213K 0.02% 679
2016
Q1 		$5.53M Sell
65,070
-6,795
-9% -$505K 0.02% 685
2015
Q4 		$5.67M Buy
71,865
+13,736
+24% +$1.08M 0.02% 708
2015
Q3 		$4.09M Sell
58,129
-16,824
-22% -$1.38M 0.01% 773
2015
Q2 		$6.76M Sell
74,953
-160,885
-68% -$15.5M 0.02% 713
2015
Q1 		$23.7M Sell
235,838
-11,538
-5% -$1.16M 0.06% 442
2014
Q4 		$24.9M Buy
247,376
+53,049
+27% +$5.29M 0.06% 421
2014
Q3 		$18.7M Buy
194,327
+56,034
+41% +$5.31M 0.05% 505
2014
Q2 		$12.9M Buy
+138,293
New +$12.1M 0.03% 593

Other funds holding MJN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $20.5B AUM 26.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Lord, Abbett & Co's MJN Position: Q1 2017 in Review

Lord, Abbett & Co sold out of Mead Johnson Nutrition Company (MJN) in Q1 2017, closing a stake of 140,650 shares — an estimated $9.95M sold.

Lord, Abbett & Co first reported a position in MJN in Q2 2014 and held it in 11 quarters. The position peaked at $24.9M in Q4 2014. 533 funds tracked by Wall St. Rank hold MJN as of Q1 2017.

  • Lord, Abbett & Co reported no remaining Mead Johnson Nutrition Company position as of Q1 2017 after selling out during the quarter.
  • Lord, Abbett & Co sold 140,650 Mead Johnson Nutrition Company shares in Q1 2017, an estimated $9.95M.
  • Lord, Abbett & Co first reported a position in Mead Johnson Nutrition Company in Q2 2014 and held it in 11 quarters.
  • Lord, Abbett & Co's Mead Johnson Nutrition Company position peaked at $24.9M in Q4 2014.
  • 533 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q1 2017.

Based on Lord, Abbett & Co's 13F filing for Q1 2017, filed 15 May 2017.